We have set up our new Discord server! Share your feedback and find like-minded people! Join our Discord

Ticker
WANBURY.NSE

Price
253.60
Stock movement down
-14.30 (-5.34%)
Company name
Wanbury Limited
Exchange
(NSE
,
Currency
INR
)
Sector
Healthcare >
Drug Manufacturers - Specialty & Generic
Market cap
8.31B
Ent value
11.83B
Price/Sales
1.44
Price/Book
21.45
Div yield
-
Div growth
-
Growth years
-
FCF payout
-
Trailing P/E
15.69
Forward P/E
-
PEG
-
EPS growth
-
1 year return
73.40%
3 year return
39.83%
5 year return
62.33%
10 year return
24.09%
Last updated: 2025-04-03

DIVIDENDS

WANBURY.NSE does not pay dividends or no data was received

VALUATION

Valuation Ratios

Valuation Ratios data
Trailing P/E15.69
Price to OCF125.04
Price to FCF125.04
Price to EBITDA38.05
EV to EBITDA54.18

Valuation (Sales/Book Value)

Valuation (Sales/Book Value) data
Price to Sales1.44
Price to Book21.45
EV to Sales2.05

FINANCIALS

Per share

Per share data
Current share count32.77M
EPS (TTM)16.12
FCF per share (TTM)2.02

Income statement

Income statement data
Revenue (TTM)5.77B
Gross profit (TTM)2.36B
Operating income (TTM)731.01M
Net income (TTM)529.62M
EPS (TTM)16.12
EPS (1y forward)-

Margins

Margins data
Gross margin (TTM)40.86%
Operating margin (TTM)12.66%
Profit margin (TTM)9.18%

Balance Sheet

Please create a free account or log in to access this chart
Balance Sheet data
Cash58.95M
Net receivables0.00
Total current assets1.90B
Goodwill0.00
Intangible assets2.40M
Property, plant and equipment0.00
Total assets3.97B
Accounts payable1.38B
Short/Current long term debt1.81B
Total current liabilities2.20B
Total liabilities3.58B
Shareholder's equity387.46M
Net tangible assets0.00

Cash flow

Please create a free account or log in to access this chart
Cash flow data
Operating cash flow (TTM)66.47M
Capital expenditures (TTM)0.00
Free cash flow (TTM)66.47M
Dividends paid (TTM)0.00

Financial returns

Please create a free account or log in to access this chart
Financial returns data
Return on Equity136.69%
Return on Assets13.35%
Return on Invested Capital53.72%
Cash Return on Invested Capital6.74%

STOCK INFORMATION

Stock chart

Stock price data
Open269.00
Daily high272.97
Daily low251.43
Daily Volume92K
All-time high321.85
1y analyst estimate-
Beta0.53
EPS (TTM)16.12
Dividend per share-
Ex-div date29 Jul 2010
Next earnings date14 May 2025

Downside potential

Downside potential data
WANBURY.NSES&P500
Current price drop from All-time high-21.21%-7.90%
Highest price drop-93.48%-56.47%
Date of highest drop18 Oct 20199 Mar 2009
Avg drop from high-64.71%-11.07%
Avg time to new high141 days12 days
Max time to new high3994 days1805 days
COMPANY DETAILS
WANBURY.NSE (Wanbury Limited) company logo
Marketcap
8.31B
Marketcap category
Mid-cap
Description
Wanbury Limited manufactures and sells formulations and active pharmaceutical ingredients (API) in India and internationally. The company offers formulations for gynecology, orthopedics, hematinic, anti-diabetic, nutraceuticals, gastro intestinal, stroke surgery, antibiotics, cough and cold solutions, anti-inflammatory, analgesics, and general practitioner. It also provides API products for anti-diabetic, anti-analgesic, anti-depressant, anti-histaminic, anti-inflammatory, anti-arthritis, anti-thrombotic, anti-epileptic, and anti-hypertensive therapeutic areas. The company was formerly known as Pearl Organics Limited and changed its name to Wanbury Limited in 2004. Wanbury Limited was incorporated in 1988 and is headquartered in Navi Mumbai, India.
Employees
1491
Website
https://www.wanbury.com
Investor relations
-
SEC filings
WANBURY.NSE SEC filings
CEO
Country
India
City
Stock type
-
CCC status
-
Dividend Frequency
-
EVENTS AND PRESENTATIONS
EventsPresentations
UNDERSTAND THE BUSINESS
COMPANY NEWS
All newsPress releases
No items found
Disclaimer
Skyfall Technology OÜ assumes no responsibility or liability for any errors or omissions in the content of this site. The information contained in this site is provided on an “as is” basis with no guarantees of completeness, accuracy, usefulness or timeliness. Please also note, that any action you take upon the information provided on this website is strictly at your own risk. This website is intended to be used and must be used for informational purposes only and you should take independent financial advice from a professional and independently research and verify everything you see on the site.
Menu
HomePortfolio ManagementCompany ScreenerGreen InvestmentExchangesContact Us
Language
ENHUNOSVDAFIESDENLFRITPTPLCSSKROELTRRUAF
© 2024 Skyfall Technology OÜ All Rights Reserved